Sagar Lonial insider trades: Tg Therapeutics (TGTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sagar reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | TGTX | ↓ Sell | 20,852 | $32.24 | $672K | Direct | Sep 12, 2025 (1d) |
| Nov 11, 2024 | TGTX | ↓ Sell | 5,000 | $30.44 | $152K | Direct | Nov 12, 2024 (1d) |
| Jun 20, 2024 | TGTX | ↓ Sell | 25,933 | $16.69 | $433K | Direct | Jun 20, 2024 (0d) |
| Mar 13, 2024 | TGTX | ↓ Sell | 5,000 | $15.94 | $80K | Direct | Mar 15, 2024 (2d) |
| Jun 23, 2023 | TGTX | ↓ Sell | 34,854 | $23.37 | $815K | Direct | Jun 26, 2023 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TGTX insiders
Open-market trades in the last 12 months
About Sagar Lonial's insider trades
Sagar Lonial is a director at Tg Therapeutics (TGTX). Since Jun 23, 2023, Sagar has reported no open-market purchases and 5 sales worth $2.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TGTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.